Loading clinical trials...
Loading clinical trials...
This phase 2 randomized study will be used to test the efficacy of 4-aminopyridine (4AP) or atenolol to reduce severity and frequency of vestibular and headache symptoms of vestibular migriane suffere...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Massachusetts Eye and Ear Infirmary
NCT04715685 · Headache, Headache Disorders, and more
NCT07170176 · Migraine Disorders, Patent Foramen Ovale, and more
NCT05674786 · Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), and more
NCT04939922 · Headache Disorders, Primary, Headache Disorders, Secondary, and more
NCT05418218 · Headache Disorders, Primary, Headache Disorders, Secondary, and more
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions